{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T04:48:38Z","timestamp":1769316518966,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Joint Construction Project of Henan Province","award":["LHGJ20190245"],"award-info":[{"award-number":["LHGJ20190245"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Peritoneal fibrosis is one of the major complications induced by peritoneal dialysis (PD). Damaged integrity and function of peritoneum caused by peritoneal fibrosis not only limits the curative efficacy of PD and but affects the prognosis of patients. However, the detailed mechanisms underlying the process remain unclear and therapeutic strategy targeting TGF\u2010\u03b2 is deficient. Transforming growth factor\u2010\u03b2 (TGF\u2010\u03b2) signaling participates in the progression of peritoneal fibrosis through enhancing mesothelial-mesenchymal transition of mesothelial cells.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study aims to demonstrate the regulatory role of Sirtuin1 (SIRT1) to the TGF\u2010\u03b2 signaling mediated peritoneal fibrosis. SIRT1<jats:sup>\u2212\/\u2212<\/jats:sup> mice were used to establish animal model. Masson\u2019s staining and peritoneal equilibration assay were performed to evaluate the degree of peritoneal fibrosis. QRT-PCR assays were used to estimate the RNA levels of Sirt1 and matrix genes related to peritoneal fibrosis, and their protein levels were examined by Western blot assays.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>SIRT1 significantly decreased in vivo post PD treatment. SIRT1 knockout exacerbated peritoneal fibrosis both in vivo and vitro. Overexpression of SIRT1 efficiently inhibited peritoneal fibrosis by inhibiting the peritoneal inflammation and the activation of TGF\u2010\u03b2 signaling.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>SIRT1 ameliorated peritoneal fibrosis both in vivo and in vitro through inhibiting the expression of protein matrix induced by TGF\u2010\u03b2 signaling.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13578-021-00591-8","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T09:21:39Z","timestamp":1619515299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Ameliorative role of SIRT1 in peritoneal fibrosis: an in vivo and in vitro study"],"prefix":"10.1186","volume":"11","author":[{"given":"Yanhong","family":"Guo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liuwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Gou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yulin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yage","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinxin","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,27]]},"reference":[{"key":"591_CR1","doi-asserted-by":"publisher","first-page":"60","DOI":"10.4103\/ijpvm.IJPVM_549_17","volume":"10","author":"S Alatab","year":"2019","unstructured":"Alatab S, Najafi I, Tabatabaei-Malazy O, Pourmand G, Ahmadbeigi N. Strategies for prevention and treatment of peritoneal fibrosis: a scientometric study. Int J Prev Med. 2019;10:60.","journal-title":"Int J Prev Med"},{"key":"591_CR2","doi-asserted-by":"publisher","first-page":"9331","DOI":"10.1038\/s41598-019-45776-x","volume":"9","author":"N Ashizawa","year":"2019","unstructured":"Ashizawa N, Miyazaki T, Abe S, Takazono T, Saijo T, Obata Y, Shimamura S, Yamamoto K, Imamura Y, Koji T, et al. Evaluation of Candida peritonitis with underlying peritoneal fibrosis and efficacy of micafungin in murine models of intra-abdominal candidiasis. Sci Rep. 2019;9:9331.","journal-title":"Sci Rep"},{"key":"591_CR3","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1021\/acs.molpharmaceut.9b00266","volume":"16","author":"K Asifullah","year":"2019","unstructured":"Asifullah K, Zhou Z, He W, Gao K, Khan MW, Faisal R, Muhammad H, Sun M. CXCR4-receptor-targeted liposomes for the treatment of peritoneal fibrosis. Mol Pharm. 2019;16:2728\u201341.","journal-title":"Mol Pharm"},{"key":"591_CR4","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1016\/j.kint.2018.12.030","volume":"95","author":"A Helmke","year":"2019","unstructured":"Helmke A, Nordlohne J, Balzer MS, Dong L, Rong S, Hiss M, Shushakova N, Haller H, von Vietinghoff S. CX3CL1-CX3CR1 interaction mediates macrophage-mesothelial cross talk and promotes peritoneal fibrosis. Kidney Int. 2019;95:1405\u201317.","journal-title":"Kidney Int"},{"key":"591_CR5","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1002\/jcp.28976","volume":"235","author":"N Jiang","year":"2020","unstructured":"Jiang N, Zhang Z, Shao X, Jing R, Wang C, Fang W, Mou S, Ni Z. Blockade of thrombospondin-1 ameliorates high glucose-induced peritoneal fibrosis through downregulation of TGF-beta1\/Smad3 signaling pathway. J Cell Physiol. 2020;235:364\u201379.","journal-title":"J Cell Physiol"},{"key":"591_CR6","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.omtn.2017.05.001","volume":"7","author":"BY Nam","year":"2017","unstructured":"Nam BY, Park JT, Kwon YE, Lee JP, Jung JH, Kim Y, Kim S, Park J, Um JE, Wu M, et al. Periostin-binding DNA aptamer treatment ameliorates peritoneal dialysis-induced peritoneal fibrosis. Mol Ther Nucleic Acids. 2017;7:396\u2013407.","journal-title":"Mol Ther Nucleic Acids"},{"key":"591_CR7","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.3390\/ijms20112610","volume":"20","author":"M Kunin","year":"2019","unstructured":"Kunin M, Carmon V, Beckerman P, Dinour D. Effect of peritoneal dialysis on serum fibrosis biomarkers in patients with refractory congestive heart failure. Int J Mol Sci. 2019;20:2610.","journal-title":"Int J Mol Sci"},{"key":"591_CR8","doi-asserted-by":"publisher","first-page":"109778","DOI":"10.1016\/j.cellsig.2020.109778","volume":"75","author":"MS Balzer","year":"2020","unstructured":"Balzer MS. Molecular pathways in peritoneal fibrosis. Cell Signal. 2020;75:109778.","journal-title":"Cell Signal"},{"key":"591_CR9","first-page":"162","volume":"70","author":"S Alatab","year":"2018","unstructured":"Alatab S, Najafi I, Atlasi R, Pourmand G, Tabatabaei-Malazy O, Ahmadbeigi N. A systematic review of preclinical studies on therapeutic potential of stem cells or stem cells products in peritoneal fibrosis. Minerva Urol Nefrol. 2018;70:162\u201378.","journal-title":"Minerva Urol Nefrol"},{"key":"591_CR10","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/path.5350","volume":"250","author":"YT Chen","year":"2020","unstructured":"Chen YT, Hsu H, Lin CC, Pan SY, Liu SY, Wu CF, Tsai PZ, Liao CT, Cheng HT, Chiang WC, et al. Inflammatory macrophages switch to CCL17-expressing phenotype and promote peritoneal fibrosis. J Pathol. 2020;250:55\u201366.","journal-title":"J Pathol"},{"key":"591_CR11","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1159\/000142529","volume":"109","author":"Q Yao","year":"2008","unstructured":"Yao Q, Pawlaczyk K, Ayala ER, Styszynski A, Breborowicz A, Heimburger O, Qian JQ, Stenvinkel P, Lindholm B, Axelsson J. The role of the TGF\/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. Nephron Exp Nephrol. 2008;109:e71-78.","journal-title":"Nephron Exp Nephrol"},{"key":"591_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/gt.2014.116","volume":"22","author":"H Yoshizawa","year":"2015","unstructured":"Yoshizawa H, Morishita Y, Watanabe M, Ishibashi K, Muto S, Kusano E, Nagata D. TGF-beta(1)-siRNA delivery with nanoparticles inhibits peritoneal fibrosis. Gene Ther. 2015;22:333\u201340.","journal-title":"Gene Ther"},{"key":"591_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/ki.2013.81","volume":"84","author":"T Ueno","year":"2013","unstructured":"Ueno T, Nakashima A, Doi S, Kawamoto T, Honda K, Yokoyama Y, Doi T, Higashi Y, Yorioka N, Kato Y, et al. Mesenchymal stem cells ameliorate experimental peritoneal fibrosis by suppressing inflammation and inhibiting TGF-beta1 signaling. Kidney Int. 2013;84:297\u2013307.","journal-title":"Kidney Int"},{"key":"591_CR14","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cyto.2010.11.004","volume":"53","author":"YM Subeq","year":"2011","unstructured":"Subeq YM, Ke CY, Lin NT, Lee CJ, Chiu YH, Hsu BG. Valsartan decreases TGF-beta1 production and protects against chlorhexidine digluconate-induced liver peritoneal fibrosis in rats. Cytokine. 2011;53:223\u201330.","journal-title":"Cytokine"},{"key":"591_CR15","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.18632\/aging.102882","volume":"12","author":"W Qian","year":"2020","unstructured":"Qian W, Cai X, Qian Q. Sirt1 antisense long non-coding RNA attenuates pulmonary fibrosis through sirt1-mediated epithelial-mesenchymal transition. Aging (Albany NY). 2020;12:4322\u201336.","journal-title":"Aging (Albany NY)"},{"key":"591_CR16","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.3390\/ijms20184607","volume":"20","author":"SJ Lee","year":"2019","unstructured":"Lee SJ, Kim SJ, Lee HS, Kwon OS. PKCdelta mediates NF-kappaB inflammatory response and downregulates SIRT1 expression in liver fibrosis. Int J Mol Sci. 2019;20:4607.","journal-title":"Int J Mol Sci"},{"key":"591_CR17","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1096\/fj.201700612r","volume":"32","author":"M Li","year":"2018","unstructured":"Li M, Hong W, Hao C, Li L, Wu D, Shen A, Lu J, Zheng Y, Li P, Xu Y. SIRT1 antagonizes liver fibrosis by blocking hepatic stellate cell activation in mice. FASEB J. 2018;32:500\u201311.","journal-title":"FASEB J"},{"key":"591_CR18","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1002\/jcb.24748","volume":"115","author":"XZ Huang","year":"2014","unstructured":"Huang XZ, Wen D, Zhang M, Xie Q, Ma L, Guan Y, Ren Y, Chen J, Hao CM. Sirt1 activation ameliorates renal fibrosis by inhibiting the TGF-beta\/Smad3 pathway. J Cell Biochem. 2014;115:996\u20131005.","journal-title":"J Cell Biochem"},{"key":"591_CR19","doi-asserted-by":"publisher","first-page":"106064","DOI":"10.1016\/j.intimp.2019.106064","volume":"78","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Huang Q, Chen Y, Peng X, Wang Y, Li S, Wu J, Luo C, Gong W, Yin B, et al. Parthenolide, an NF-kappaB inhibitor, alleviates peritoneal fibrosis by suppressing the TGF-beta\/Smad pathway. Int Immunopharmacol. 2020;78:106064.","journal-title":"Int Immunopharmacol"},{"key":"591_CR20","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1681\/ASN.2009070694","volume":"21","author":"O Devuyst","year":"2010","unstructured":"Devuyst O, Margetts PJ, Topley N. The pathophysiology of the peritoneal membrane. J Am Soc Nephrol. 2010;21:1077\u201385.","journal-title":"J Am Soc Nephrol"},{"key":"591_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.mehy.2013.03.036","volume":"81","author":"F Zhang","year":"2013","unstructured":"Zhang F, Liu H, Liu F, Peng Y, Chen M, Liu Y, Chen G. New insights into the pathogenesis and treatment of peritoneal fibrosis: a potential role of Wnt\/beta-catenin induced epithelial to mesenchymal transition and stem cells for therapy. Med Hypotheses. 2013;81:97\u2013100.","journal-title":"Med Hypotheses"},{"key":"591_CR22","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.prp.2018.12.022","volume":"215","author":"J Li","year":"2019","unstructured":"Li J, Li SX, Gao XH, Zhao LF, Du J, Wang TY, Wang L, Zhang J, Wang HY, Dong R, Guo ZY. HIF1A and VEGF regulate each other by competing endogenous RNA mechanism and involve in the pathogenesis of peritoneal fibrosis. Pathol Res Pract. 2019;215:644\u201352.","journal-title":"Pathol Res Pract"},{"key":"591_CR23","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13287-020-01878-2","volume":"11","author":"Y Guo","year":"2020","unstructured":"Guo Y, Wang L, Gou R, Wang Y, Shi X, Pang X, Tang L. SIRT1-modified human umbilical cord mesenchymal stem cells ameliorate experimental peritoneal fibrosis by inhibiting the TGF-beta\/Smad3 pathway. Stem Cell Res Ther. 2020;11:362.","journal-title":"Stem Cell Res Ther"},{"key":"591_CR24","doi-asserted-by":"publisher","first-page":"3543678","DOI":"10.1155\/2016\/3543678","volume":"2016","author":"R Strippoli","year":"2016","unstructured":"Strippoli R, Moreno-Vicente R, Battistelli C, Cicchini C, Noce V, Amicone L, Marchetti A, Del Pozo MA, Tripodi M. Molecular mechanisms underlying peritoneal EMT and fibrosis. Stem Cells Int. 2016;2016:3543678.","journal-title":"Stem Cells Int"},{"key":"591_CR25","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5527\/wjn.v6.i3.111","volume":"6","author":"CY Yang","year":"2017","unstructured":"Yang CY, Chau YP, Chen A, Lee OK, Tarng DC, Yang AH. Targeting cannabinoid signaling for peritoneal dialysis-induced oxidative stress and fibrosis. World J Nephrol. 2017;6:111\u20138.","journal-title":"World J Nephrol"},{"key":"591_CR26","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.ajpath.2013.05.019","volume":"183","author":"Q Zhou","year":"2013","unstructured":"Zhou Q, Yang M, Lan H, Yu X. miR-30a negatively regulates TGF-beta1-induced epithelial-mesenchymal transition and peritoneal fibrosis by targeting Snai1. Am J Pathol. 2013;183:808\u201319.","journal-title":"Am J Pathol"},{"key":"591_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nature02006","volume":"425","author":"R Derynck","year":"2003","unstructured":"Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425:577\u201384.","journal-title":"Nature"},{"key":"591_CR28","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1093\/ndt\/gfy282","volume":"34","author":"MS Balzer","year":"2019","unstructured":"Balzer MS, Helmke A, Ackermann M, Casper J, Dong L, Hiss M, Kiyan Y, Rong S, Timrott K, von Vietinghoff S, et al. Protein kinase C beta deficiency increases glucose-mediated peritoneal damage via M1 macrophage polarization and up-regulation of mesothelial protein kinase C alpha. Nephrol Dial Transplant. 2019;34:947\u201360.","journal-title":"Nephrol Dial Transplant"},{"key":"591_CR29","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/ki.2011.327","volume":"81","author":"XM Meng","year":"2012","unstructured":"Meng XM, Huang XR, Xiao J, Chung AC, Qin W, Chen HY, Lan HY. Disruption of Smad4 impairs TGF-beta\/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro. Kidney Int. 2012;81:266\u201379.","journal-title":"Kidney Int"},{"key":"591_CR30","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/ndt\/gfq032","volume":"25","author":"AO Phillips","year":"2010","unstructured":"Phillips AO, Fraser DJ. BMP-7 stops TGF-{beta} in peritoneal fibrosis. Nephrol Dial Transplant. 2010;25:1036\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"591_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1177\/000992286600501216","volume":"5","author":"SJ Stamm","year":"1966","unstructured":"Stamm SJ, Doctor J, Rose R, Isbister J, Hickman R. Peritoneal dialysis in the treatment of cystic fibrosis with congestive heart failure. Clin Pediatr (Phila). 1966;5:755\u20139.","journal-title":"Clin Pediatr (Phila)"},{"key":"591_CR32","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/annrheumdis-2014-205740","volume":"75","author":"P Zerr","year":"2016","unstructured":"Zerr P, Palumbo-Zerr K, Huang J, Tomcik M, Sumova B, Distler O, Schett G, Distler JH. Sirt1 regulates canonical TGF-beta signalling to control fibroblast activation and tissue fibrosis. Ann Rheum Dis. 2016;75:226\u201333.","journal-title":"Ann Rheum Dis"},{"key":"591_CR33","doi-asserted-by":"publisher","first-page":"30513","DOI":"10.1038\/srep30513","volume":"6","author":"L Sun","year":"2016","unstructured":"Sun L, Fan Z, Chen J, Tian W, Li M, Xu H, Wu X, Shao J, Bian Y, Fang M, Xu Y. Corrigendum: transcriptional repression of SIRT1 by protein inhibitor of activated STAT 4 (PIAS4) in hepatic stellate cells contributes to liver fibrosis. Sci Rep. 2016;6:30513.","journal-title":"Sci Rep"},{"key":"591_CR34","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/jcmm.14757","volume":"24","author":"L Han","year":"2020","unstructured":"Han L, Tang Y, Li S, Wu Y, Chen X, Wu Q, Hong K, Li J. Protective mechanism of SIRT1 on Hcy-induced atrial fibrosis mediated by TRPC3. J Cell Mol Med. 2020;24:488\u2013510.","journal-title":"J Cell Mol Med"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00591-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-021-00591-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-021-00591-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T09:45:30Z","timestamp":1619516730000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-021-00591-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["591"],"URL":"https:\/\/doi.org\/10.1186\/s13578-021-00591-8","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,27]]},"assertion":[{"value":"15 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal studies were approved by the ethics commitment of Henan Provincial Hospital of Traditional Chinese Medicine.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants have given consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"79"}}